Eisai Co., Ltd. announced today that amyotrophic lateral sclerosis (ALS) treatment “Rozebalamin® for Injection 25 mg” ...

A toxic version of a certain protein may affect brain, spinal cord and skeletal muscle tissues differently, leading to the ...

Amyotrophic lateral sclerosis is a neurodegenerative disease characterised by selective degeneration of motor neurons. This process results in deterioration of muscle strength in the limbs and bulbar ...

Mitsubishi Tanabe Pharma America, Inc. (MTPA) today announced that twelve presentations following expansive research in amyotrophic lateral sclerosis (ALS) will be shared as part of the Northeast ...

When April Kerner first started losing her voice, she wasn't sure she would be able to communicate with her family ever again ...

A participant with amyotrophic lateral sclerosis (ALS) and severe dysarthria underwent surgical implantation of ...

The Scott-Morgan Foundation is launching a joint initiative that aims to use AI technologies to help improve communication ...

Each year, rigorous science and dazzling artistry meet in Nikon's "Small World" photomicrography competition. See the 2024 ...

PRESS RELEASE AB SCIENCE PROVIDES AN UPDATE ON THE APPLICATION FOR CONDITIONAL MARKETING AUTHORISATION OF MA ...

When Brooke Eby was diagnosed with amyotrophic lateral sclerosis (ALS), Salesforce surprised her with an outpouring of ...

Oditrasertib, which blocks the inflammatory RIPK1 protein, earlier this year also failed a Phase II trial in amyotrophic ...

RNS60 is an experimental therapy designed to boost the formation of new mitochondria and restore energy production in nerve ...